Меню
Набор скоро начнётся NCT06374407

The MIND-GUT Digital Pilot Intervention Study

Без фазы С лечением Obesity Depressive Symptoms Anxiety Stress

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Dietary intervention based on the MIND diet.
Кому может быть актуально
Состояния в реестре: Obesity, Depressive Symptoms, Anxiety, Stress. Базовые параметры: 30 лет — 50 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Швеция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Exploring the Interplay Between Diet, Obesity, Mental Health, and the Gut Microbiome. The MIND-GUT Digital Pilot Intervention Study.

Обзор

This 12-week pilot study aims to evaluate the feasibility and effectiveness of a dietary intervention targeting diet, obesity, mental health, and the gut microbiome in promoting weight loss and enhancing mental health among obese men and women aged 30-50. Participants, excluding those with specific medical conditions, will be randomly assigned to either an intervention or control group using a meal planning smartphone app. Clinical assessments will include anthropometry, mental health questionnaires, dietary recalls, and stool sample collections. The study's endpoints include program retention, adherence, changes in body weight, mental health, and gut microbiome diversity. Statistical analyses will evaluate intervention effects and the potential mediating roles of the gut microbiome. This pilot study has implications for health policies, public healthcare, digital health companies, and the biotech and pharmacology industries. Future plans involve a large-scale intervention study in multiple countries with ongoing collaborations.

Подробное описание

Objective of the Pilot Study and Study Design:

This 12-week randomized pilot intervention study aims to assess the feasibility and effectiveness of a dietary intervention targeting diet, obesity, mental health, and the gut microbiome in promoting weight loss and enhancing mental health among obese individuals aged 30-50.

Participant Recruitment and Randomization:

Participants aged 30-50, excluding those with specific medical conditions such as psychiatric medication use, food allergies affecting diets, eating disorders, diabetes, polycystic ovary syndrome, sensory deficits, recent antibiotic use, participation in other studies, language limitations, coeliac/inflammatory bowel disease, planned weight management within 3 months, and pregnant/lactating/post-menopausal women, will be recruited for the study. Randomization will be conducted to assign eligible participants to either an intervention or control group using a meal planning smartphone app.

Clinical Assessments:

Clinical assessments will include anthropometry, mental health questionnaires, dietary recalls, and stool sample collections.

Study Endpoints:

The study's endpoints include program retention, adherence, changes in body weight, mental health, and gut microbiome diversity.

Statistical Analyses:

Statistical analyses will evaluate the study feasibility, intervention effects on body weight and mental health changes, and the potential mediating roles of these effects by the gut microbiome.

Implications and Future Plans:

This pilot study has implications for health policies, public healthcare, digital health companies, and the biotech and pharmacology industries. Future plans involve a large-scale intervention study in multiple countries with ongoing collaborations.

Вмешательства

  • Поведенческое Dietary intervention based on the MIND diet
    A 12-week pilot randomized controlled trial (RCT) involving N=126 obese participants (1:1 gender ratio) to assess protocol feasibility, including recruitment, retention, compliance, physical examinations, and gut sample collection. Sample size, calculated by a statistician, expects a 5% body weight change at follow-up (std. dev. 10%). We chose a 12-week duration for this pilot study to allow sufficient time to observe significant changes in both body weight and mental health.

Первичные конечные точки

  • Program retention [Срок оценки: 12 weeks]
  • Adherence [Срок оценки: 12 weeks]
  • Acceptability [Срок оценки: 12 weeks]
  • Study effectiveness: change in eating attitudes at follow-up [Срок оценки: 12 weeks]
  • Study effectiveness: change in stress levels at follow-up [Срок оценки: 12 weeks]
  • Study effectiveness: change in depression symptoms at follow-up [Срок оценки: 12 weeks]
  • Study effectiveness: change in anxiety symtoms at follow-up [Срок оценки: 12 weeks]
  • Study effectiveness: change in body weight at follow-up [Срок оценки: 12 weeks]
  • Study effectiveness: change in % total fat mass at follow-up [Срок оценки: 12 weeks]
  • Study effectiveness: change in % visceral fat mass at follow-up [Срок оценки: 12 weeks]

Критерии участия

Критерии включения

  • age 30- 50;
  • BMI ≥ 30 kg/m2;
  • stable physical activity;
  • one person per household;
  • commitment to full protocol.

Критерии исключения

  • use of psychiatric medications (e.g., serotonin reuptake inhibitors);
  • use of weight loss medications (GLP-1 receptor agonists);
  • food allergies affecting adherence to the MIND diet;
  • diagnosis of eating disorders;
  • diagnosis of diabetes;
  • diagnosis of polycystic ovary syndrome;
  • sensory deficits (e.g., COVID-19-induced loss of taste/smell);
  • antibiotic use during the latest 3 months;
  • participation in another study;
  • language understanding limitations (i.e., not able to understand either Swedish or English); - coeliac/inflammatory bowel disease;
  • planned weight management program within three months;
  • pregnancy;
  • lactation;
  • menopause.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Четверное слепое
Основная цель
Лечение

Центры проведения

Швеция · 1 центр
  • University of Skövde — Skövde

Идентификаторы

NCT: NCT06374407 · GT-001

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗